Catherine Burzik Reinstated as Orthofix Board Chair

Orthofix Medical Inc. has re-appointed Catherine Burzik as board chair.

In addition, Orthofix shareholders re-elected former board member Wayne Burris, who was part of the governing body from 2021-2022. Burris now serves on the Audit and Finance, and Compliance and Ethics committees. Jon Serbousek, who was executive board chairman, was not up for re-election at the annual shareholders meeting.
 
Burzik previously chaired the company’s board from 2021-2022 before becoming lead independent director of the new Orthofix-SeaSpine combined board. Prior to her Orthofix board stint, Burzik was president and CEO of Kinetic Concepts Inc. from 2006 until the company’s sale in 2011. Prior to that, she was president of Applied Biosystems Group and held senior executive positions at Eastman Kodak Health Imaging Systems. She was also president of Ortho-Clinical Diagnostics Inc., a Johnson & Johnson company.
 
“I am honored to step back into the role of chair for Orthofix,” Burzik said. “I would like to thank Jon for his leadership and commitment to the company and the merger integration. I am grateful for the counsel he provided as both the CEO of Orthofix and as the executive chairman of the board and we wish him the best as he continues his work to advance the medical device industry. I am also pleased to welcome back Wayne Burris whose dedication and strong background in accounting and finance will help guide us to long-term success.”

Burris was senior vice president and chief financial officer (CFO) at Roche Diagnostics Corporation from 1996 through his retirement in July 2019. A member of the Global Roche Diagnostics Finance Executive Committee, Burris was recognized as one of the company’s top senior leaders.
 
“I am delighted to rejoin the Orthofix Board of Directors,” Burris stated. “I look forward to working with Keith Valentine and his leadership team to drive collaboration as the new merged company strives to be the partner of choice for our surgeon customers.”
  
The newly merged Orthofix-SeaSpine organization is a global spine and orthopedics company with a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions and a surgical navigation system. Its products are distributed in more than 68 countries worldwide. The company is headquartered in Lewisville, Texas, and has primary offices in Carlsbad, Calif., with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, Calif.; Toronto, Canada; Sunnyvale, Calif.; Wayne, Pa.; Olive Branch, Miss.; Maidenhead, U.K.; Munich, Germany; Paris;, and São Paulo, Brazil.